Astonea Labs IPO: Comprehensive Peer Comparison with Pharmaceutical Companies
This peer comparison evaluates Astonea Labs IPO against key competitors like Beta Drugs limited. By analysing essential financial metrics such as EPS, ROCE, ROE, P/E ratio, P/Bv, and Debt/Equity, investors can gain insights into the relative performance and valuation of these Pharmaceutical Company. This comparison highlights the strengths and positioning of Astonea Labs in the competitive landscape of the Pharmaceutical Industry.
Astonea Labs Limited IPO Peer Comparison |
|||||||||||
Company Name | EPS | ROCE | ROE | P/E (x) | P/Bv | Debt/Equity | RoNW (%) | ||||
Astonea Labs Limited | ₹ 3.62 | 22.95 % | 37.86 % | 37.25 | 8.57 | 2.16 | 31.83 % | ||||
Beta Drugs limited | ₹ 42.0 | 27.3 % | 25.8 % | 39.5 | 9.18 | 0.67 | 25.8 % |
Option Trading with CA Abhay
Stock Market Masterclass
Equity Trading with CA Abhay
Equity Investment with CA Abhay
FNO Stocks with CA Abhay
Stock Market Masterclass
FNO Stocks with CA Abhay
Equity Investment with CA Abhay
Option Trading with CA Abhay
Equity Trading with CA Abhay
Copyright @2020 Design & Developed by Info Web Software